1. Home
  2. GEOS vs GANX Comparison

GEOS vs GANX Comparison

Compare GEOS & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

HOLD

Current Price

$5.89

Market Cap

90.5M

Sector

Industrials

ML Signal

HOLD

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$2.05

Market Cap

74.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEOS
GANX
Founded
1980
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
90.5M
74.6M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
GEOS
GANX
Price
$5.89
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
148.0K
508.3K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.46
EPS
N/A
N/A
Revenue
$110,803,000.00
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.05
$1.53
52 Week High
$29.89
$4.34

Technical Indicators

Market Signals
Indicator
GEOS
GANX
Relative Strength Index (RSI) 39.86 59.02
Support Level N/A $1.64
Resistance Level $7.54 $2.05
Average True Range (ATR) 0.45 0.13
MACD -0.06 0.03
Stochastic Oscillator 26.85 53.65

Price Performance

Historical Comparison
GEOS
GANX

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: